Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Up 0.9 %

Shares of RVP opened at $1.07 on Wednesday. Retractable Technologies has a 52-week low of $0.95 and a 52-week high of $1.90. The business’s fifty day moving average is $1.21 and its 200-day moving average is $1.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.41 and a current ratio of 8.28. The firm has a market cap of $32.03 million, a price-to-earnings ratio of -4.46 and a beta of 2.11.

Hedge Funds Weigh In On Retractable Technologies

Several hedge funds and other institutional investors have recently modified their holdings of RVP. Millennium Management LLC acquired a new stake in shares of Retractable Technologies during the 2nd quarter valued at $880,000. Vanguard Group Inc. boosted its holdings in shares of Retractable Technologies by 12.6% during the 1st quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company’s stock valued at $5,188,000 after acquiring an additional 122,231 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Retractable Technologies by 512.2% during the 2nd quarter. AQR Capital Management LLC now owns 107,890 shares of the company’s stock valued at $413,000 after acquiring an additional 90,267 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Retractable Technologies by 248.3% during the 2nd quarter. Renaissance Technologies LLC now owns 121,900 shares of the company’s stock worth $467,000 after buying an additional 86,900 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in Retractable Technologies by 314.2% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company’s stock worth $96,000 after buying an additional 44,300 shares during the period. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.